IBIO
iBio, Inc.
1.10$
+1.4%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +159.0% | +78.3% | +2.0% | +2.3% | +28.1% | +7.7% | +57.0% | -63.6% | -9.4% | -76.7% | -69.8% | |
| – | +36.2% | -18.9% | -23.8% | -68.7% | +61.0% | +308.8% | +176.0% | +0.3% | -53.6% | -24.9% | -10.3% | |
| – | -60.0% | +162.3% | -17.7% | -49.5% | -7.6% | +385.3% | +201.8% | +381.8% | – | – | – | |
| – | -36.2% | -21.0% | -69.7% | +1,551.1% | -67.7% | -2,473.2% | – | +81.0% | -154.0% | – | +426.5% | |
| – | -68.4% | +2,242.6% | -32.3% | -8.2% | +16.6% | +347.3% | +42.0% | -21.7% | -96.3% | -92.4% | +3,512.5% | |
| – | -68.4% | +2,242.6% | -32.3% | -8.2% | +16.6% | +2,194.5% | -80.6% | – | -87.1% | -18.1% | -4,412.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -33.5% | -100.0% | – | +27.2% | +25,562.3% | – | – | – | -82.1% | -100.0% | – | |
| – | +0.0% | -69.9% | +7.6% | +7.7% | +641.6% | -77.3% | +1,661.3% | +56.5% | -87.5% | -38.9% | – | |
| – | +99.4% | -100.8% | – | -84.6% | +1,788.0% | +20.9% | -107.4% | – | +964.5% | -63.5% | +1,054.1% | |
| – | +129.0% | -210.4% | – | -246.7% | – | -56.0% | -345.5% | – | – | -182.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.